Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.405 EUR | -0.71% | -2.43% | -7.87% |
05-15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
05-14 | Medigene Ag Maintains Earnings Guidance for 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
37.52M | - | |||||
115B | ||||||
106B | ||||||
21.84B | - | |||||
21.96B | - | |||||
19.21B |
- Stock Market
- Equities
- MDG1 Stock
- Charts Medigene AG
- Sector Chart